Johnson & Johnson Seeks Authorization For COVID Vaccine Booster Shots

The transcript discusses the potential approval of a booster for Johnson & Johnson's single-dose COVID vaccine. The emergency use application would cover boosters for individuals aged 18 and up, but does not specify the waiting period for receiving the booster. An FDA advisory panel is set to review data from both Johnson & Johnson and Moderna next week.

What type of vaccine is Johnson and Johnson's booster related to?

Which two companies' data will the FDA advisers review?